Zimmer Biomet Holdings, Inc.

NYSE:ZBH

Medical - Devices

Healthcare
$103.32 +1.00%

+$0.87 today

Market cap
$19.55B
Beta
0.47
P/E (TTM)
22.5
EPS (TTM)
$3.90
Dividend yield
1.09%
52W Low $79.12High $108.29

Volume 2.34M

Average 2.28M

ZBH Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

Zimmer Biomet Holdings, Inc.NYSE: ZBH

Income Tax Expense · Q2 FY2026 · quarter ended Jun 2026

Income tax expense declines year over year

Q2 FY2026 income tax expense of $55.5M fell 22.1% year over year, behind the -14.3% change in trailing-twelve-month income tax expense. Sequentially, it fell 11.9% from the prior quarter. Over 3 fiscal years it compounded at +3.8% a year.

Context

  • Income tax expense amounted to 1.5% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Income tax expense increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -22.1% toward the trailing-twelve-month pace of -14.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$55.5M-11.9% QoQ
Last fiscal yearDec 2025
$125.7M-4.3% YoY
LTMJun 2026
$126.6M-14.3% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-22.1%——
1 year-4.3%——
3-year CAGR+3.8%——
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
125.7M USD
Year-over-year change
-4.3%
4-year CAGR
+23.8%

Income Tax Expense vs competitors

How ZBH compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -14.3% is the 6th highest of 10, against a peer median of -7.3%.
  • Income tax expense amounts to 1.5% of revenue for ZBH, versus a peer median of 2.5%.
ZBH Competitors
Income Tax Expense for ZBH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SYKStryker CorporationLTM Jun 2026$1.42B USD+227.7%+57.4%5.5%
MDTMedtronic plcLTM Jul 2026$1.33B USD+37.1%-6.3%3.6%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$446M USD-7.3%+2.9%2.2%
EWEdwards Lifesciences CorporationLTM Jun 2026$439M USD+99.2%-4.0%6.7%
PHGKoninklijke Philips N.V.LTM Jun 2026€364M EUR-42.8%—2.1%
BSXBoston Scientific CorporationLTM Jun 2026$193M USD-61.6%+3.6%0.9%
ALGNAlign Technology, Inc.LTM Jun 2026$155.33M USD-15.1%-9.7%3.8%
SNNSmith & Nephew plcFY2025$154M USD+79.1%+134.1%2.5%
ZBHZimmer Biomet Holdings, Inc.LTM Jun 2026$126.6M USD-14.3%+3.8%1.5%
OFIXOrthofix Medical Inc.LTM Mar 2026$495K USD-77.8%-12.2%0.1%
Peer median (excluding ZBH) —-7.3%-0.6%2.5%

Competitors are the stored peer set for ZBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue6.83B6.94B7.39B7.68B8.23B
Cost of Revenue1.96B2.02B2.08B2.19B3.16B
Gross Profit4.87B4.92B5.31B5.49B5.07B
Gross Margin71.3%70.9%71.8%71.5%61.6%
Research & Development435.8M406M458.7M437.4M458.5M
Selling, General & Admin2.84B2.76B2.84B2.93B3.25B
Operating Expenses4.01B4.22B4.03B4.2B3.71B
Depreciation & Amortization937.7M926.4M951.7M996.3M1.09B
EBITDA1.65B1.49B2.22B2.25B2.22B
EBITDA Margin24.1%21.5%30.0%29.3%26.9%
Operating Income860.3M696.3M1.28B1.29B1.36B
Operating Margin12.6%10.0%17.3%16.7%16.5%
Interest Income00000
Interest Expense208.4M164.8M201.2M218M292.8M
Other Income / Expenses(361.3M)(292.8M)(210.4M)(249.1M)(531.4M)
Income Before Tax499M403.5M1.07B1.04B830.8M
Pre-Tax Margin7.3%5.8%14.4%13.5%10.1%
Income Tax Expense53.5M112.3M42.2M131.4M125.7M
Net Income401.6M231.4M1.02B903.8M705.2M
Net Margin5.9%3.3%13.8%11.8%8.6%
EPS (Basic)1.871.104.914.453.56
EPS (Diluted)1.851.104.884.433.55
Weighted Avg Shares214.86M209.6M208.7M203.1M198M
Weighted Avg Shares (Diluted)216.71M210.3M209.7M203.9M198.7M

Zimmer Biomet Holdings, Inc.

NYSE:ZBH

Intrinsic Alpha fair value

Locked

Current Price

$103.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.